Beijing Foyou Pharma CO.,LTD (SHA:601089)
China
· Delayed Price · Currency is CNY 25.54
+0.69 (2.78%)
At close: Dec 4, 2025
SHA:601089 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Operating Revenue | 3,407 | 3,433 | 3,328 | 3,237 | 2,838 | 2,535 | Upgrade
|
| Other Revenue | 12.36 | 12.36 | 11.97 | 3.15 | - | - | Upgrade
|
| Revenue | 3,419 | 3,446 | 3,340 | 3,240 | 2,838 | 2,535 | Upgrade
|
| Revenue Growth (YoY) | -0.13% | 3.17% | 3.07% | 14.18% | 11.93% | 4.56% | Upgrade
|
| Cost of Revenue | 1,165 | 1,145 | 1,128 | 1,040 | 874.82 | 733.76 | Upgrade
|
| Gross Profit | 2,255 | 2,301 | 2,212 | 2,200 | 1,963 | 1,802 | Upgrade
|
| Selling, General & Admin | 1,342 | 1,392 | 1,353 | 1,492 | 1,403 | 1,341 | Upgrade
|
| Research & Development | 396.62 | 417.37 | 353.33 | 238.4 | 176.87 | 138.16 | Upgrade
|
| Other Operating Expenses | 35.48 | 21.85 | 26.27 | 34.56 | 30.43 | 23.62 | Upgrade
|
| Operating Expenses | 1,776 | 1,833 | 1,730 | 1,767 | 1,608 | 1,504 | Upgrade
|
| Operating Income | 479.05 | 468.41 | 481.62 | 432.97 | 354.75 | 297.35 | Upgrade
|
| Interest Expense | -1.97 | -3.5 | -5.34 | -4.76 | -6.51 | -11.1 | Upgrade
|
| Interest & Investment Income | 34.12 | 49.25 | 58.02 | 35.83 | 7.98 | 6.05 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.37 | 0.37 | 0.05 | 0.39 | -0.06 | -0.23 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.46 | -0.63 | -0.68 | -1.18 | -2.48 | -1.01 | Upgrade
|
| EBT Excluding Unusual Items | 508.11 | 513.91 | 533.67 | 463.25 | 353.68 | 291.05 | Upgrade
|
| Gain (Loss) on Sale of Assets | -7.28 | 1.04 | 0.23 | 0.14 | 0.01 | -0.65 | Upgrade
|
| Asset Writedown | -1.32 | - | - | - | -1.13 | -10.39 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.54 | - | Upgrade
|
| Other Unusual Items | 25.17 | 25.17 | 15.26 | 22.56 | 13.67 | 19.77 | Upgrade
|
| Pretax Income | 524.68 | 540.12 | 549.15 | 485.95 | 365.69 | 299.78 | Upgrade
|
| Income Tax Expense | 58.89 | 48.04 | 56.81 | 46.33 | 49.79 | 35.28 | Upgrade
|
| Earnings From Continuing Operations | 465.79 | 492.08 | 492.34 | 439.62 | 315.91 | 264.5 | Upgrade
|
| Minority Interest in Earnings | -2.72 | -3.4 | -3.57 | -0.72 | -1.44 | -1.79 | Upgrade
|
| Net Income | 463.07 | 488.67 | 488.77 | 438.9 | 314.47 | 262.71 | Upgrade
|
| Net Income to Common | 463.07 | 488.67 | 488.77 | 438.9 | 314.47 | 262.71 | Upgrade
|
| Net Income Growth | -9.20% | -0.02% | 11.36% | 39.57% | 19.70% | 20.09% | Upgrade
|
| Shares Outstanding (Basic) | 477 | 470 | 479 | 422 | 361 | 360 | Upgrade
|
| Shares Outstanding (Diluted) | 477 | 470 | 479 | 422 | 361 | 360 | Upgrade
|
| Shares Change (YoY) | 0.96% | -1.94% | 13.55% | 16.75% | 0.44% | 0.35% | Upgrade
|
| EPS (Basic) | 0.97 | 1.04 | 1.02 | 1.04 | 0.87 | 0.73 | Upgrade
|
| EPS (Diluted) | 0.97 | 1.04 | 1.02 | 1.04 | 0.87 | 0.73 | Upgrade
|
| EPS Growth | -10.07% | 1.96% | -1.92% | 19.54% | 19.18% | 19.67% | Upgrade
|
| Free Cash Flow | 58.85 | 299.23 | 189.82 | 524.36 | 335.05 | 217.69 | Upgrade
|
| Free Cash Flow Per Share | 0.12 | 0.64 | 0.40 | 1.24 | 0.93 | 0.60 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.400 | 0.300 | 0.300 | Upgrade
|
| Dividend Growth | - | - | 25.00% | 33.33% | - | - | Upgrade
|
| Gross Margin | 65.94% | 66.78% | 66.22% | 67.91% | 69.17% | 71.06% | Upgrade
|
| Operating Margin | 14.01% | 13.59% | 14.42% | 13.36% | 12.50% | 11.73% | Upgrade
|
| Profit Margin | 13.54% | 14.18% | 14.64% | 13.55% | 11.08% | 10.36% | Upgrade
|
| Free Cash Flow Margin | 1.72% | 8.68% | 5.68% | 16.18% | 11.81% | 8.59% | Upgrade
|
| EBITDA | 565.47 | 551.98 | 561.39 | 499.93 | 413.17 | 341.56 | Upgrade
|
| EBITDA Margin | 16.54% | 16.02% | 16.81% | 15.43% | 14.56% | 13.47% | Upgrade
|
| D&A For EBITDA | 86.42 | 83.57 | 79.77 | 66.96 | 58.42 | 44.22 | Upgrade
|
| EBIT | 479.05 | 468.41 | 481.62 | 432.97 | 354.75 | 297.35 | Upgrade
|
| EBIT Margin | 14.01% | 13.59% | 14.42% | 13.36% | 12.50% | 11.73% | Upgrade
|
| Effective Tax Rate | 11.22% | 8.89% | 10.35% | 9.53% | 13.61% | 11.77% | Upgrade
|
| Revenue as Reported | 3,419 | 3,446 | 3,340 | 3,240 | - | - | Upgrade
|
| Advertising Expenses | - | 37.65 | 45.32 | 25.17 | 26.19 | 20.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.